Other News

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, today announces its unaudited financial results for the six months ended 31 December 2023.   Please click here to read in full....

11th of February was the International Day of Women and Girls in Science. On a day that was created to promote equal representation and gender equality in the science, technology, engineering and mathematics (STEM) disciplines, Physiomics are proud to have a team of scientist that is made up of 50% women. To mark the occasion, we have taken the opportunity to celebrate and get to...

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to provide notice of the Company’s Annual General Meeting (“AGM”).   The AGM will be held at 10.30 a.m. on 21 November 2023 at the Company’s new registered office, Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, OX14 4SB.   Shareholders will shortly be sent...

Physiomics plc (AIM: PYC), a leading mathematical modelling company, supporting development of oncology drugs and personalised medicine solutions, is pleased to announce that it has been awarded its first contract with a new UK-based biotech client.  The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year. Physiomics CEO, Dr Jim...

Physiomics to present and exhibit at SITC Annual Meeting   Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it is participating in the 37th Annual Meeting of the Society for Immunotherapy of Cancer (“SITC”), being held on 8-12 November 2022 in Boston, USA.   The Company will be presenting an...

Physiomics is pleased to announce that has been named as a finalist in the 2019 Oxford Biotech Network awards.  See this link for further details https://obn-awards.com/award-finalists-and-sponsors...